Lack of Conserved MiRNA Deregulation in HPV-Induced Squamous Cell Carcinomas

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2021 Jun 2

PMID 34065237

Citations 5

Authors

Jaroslav Nunvar

Lucie Pagacova

Zuzana Vojtechova

Nayara Trevisan Doimo de Azevedo

Jana Smahelova

Martina Salakova

Ruth Tachezy

Affiliations

Soon will be listed here.

Abstract

Squamous cell carcinomas (SCCs) in the anogenital and head and neck regions are associated with high-risk types of human papillomaviruses (HR-HPV). Deregulation of miRNA expression is an important contributor to carcinogenesis. This study aimed to pinpoint commonly and uniquely deregulated miRNAs in cervical, anal, vulvar, and tonsillar tumors of viral or non-viral etiology, searching for a common set of deregulated miRNAs linked to HPV-induced carcinogenesis. RNA was extracted from tumors and nonmalignant tissues from the same locations. The miRNA expression level was determined by next-generation sequencing. Differential expression of miRNAs was calculated, and the patterns of miRNA deregulation were compared between tumors. The total of deregulated miRNAs varied between tumors of different locations by two orders of magnitude, ranging from 1 to 282. The deregulated miRNA pool was largely tumor-specific. In tumors of the same location, a low proportion of miRNAs were exclusively deregulated and no deregulated miRNA was shared by all four types of HPV-positive tumors. The most significant overlap of deregulated miRNAs was found between tumors which differed in location and HPV status (HPV-positive cervical tumors vs. HPV-negative vulvar tumors). Our results imply that HPV infection does not elicit a conserved miRNA deregulation in SCCs.

Citing Articles

New evidence for miRNA testing in head and neck squamous cell cancer patients.

Galindo Torres B, Alcaraz Ortega R, Saiz Lopez P, Adiego Leza M, Moradillo Renuncio M, Garcia Giron C Clin Transl Oncol. 2025; .

PMID: 39913046 DOI: 10.1007/s12094-025-03854-9.

The Role of Biomarkers in HPV-Positive Head and Neck Squamous Cell Carcinoma: Towards Precision Medicine.

Krsek A, Baticic L, Sotosek V, Braut T Diagnostics (Basel). 2024; 14(13).

PMID: 39001338 PMC: 11241541. DOI: 10.3390/diagnostics14131448.

Dysregulated microRNA Expression Relevant to Promoter Mutations in Tonsil Cancer-A Pilot Study.

Kwon M, Park H, Lee J, Kim E, Kim N, Nam E Life (Basel). 2023; 13(10).

PMID: 37895471 PMC: 10608590. DOI: 10.3390/life13102090.

Expression and molecular regulation of non-coding RNAs in HPV-positive head and neck squamous cell carcinoma.

Guo D, Yang M, Li S, Zhu W, Chen M, Pan J Front Oncol. 2023; 13:1122982.

PMID: 37064141 PMC: 10090466. DOI: 10.3389/fonc.2023.1122982.

Characterizing the Inflammatory Microenvironment in K14-HPV16 Transgenic Mice: Mast Cell Infiltration and MicroRNA Expression.

Costa A, Santos J, Medeiros-Fonseca B, Oliveira P, Bastos M, Brito H Cancers (Basel). 2022; 14(9).

PMID: 35565345 PMC: 9099850. DOI: 10.3390/cancers14092216.

References

Yang X, Wu X . miRNA expression profile of vulvar squamous cell carcinoma and identification of the oncogenic role of miR-590-5p. Oncol Rep. 2015; 35(1):398-408. DOI: 10.3892/or.2015.4344. View

Wang S, Jin S, Liu M, Pang P, Wu H, Qi Z . Hsa-let-7e-5p Inhibits the Proliferation and Metastasis of Head and Neck Squamous Cell Carcinoma Cells by Targeting Chemokine Receptor 7. J Cancer. 2019; 10(8):1941-1948. PMC: 6547991. DOI: 10.7150/jca.29536. View

Koshizuka K, Hanazawa T, Kikkawa N, Arai T, Okato A, Kurozumi A . Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer. Cancer Sci. 2017; 108(8):1681-1692. PMC: 5543473. DOI: 10.1111/cas.13298. View

Kinoshita T, Nohata N, Hanazawa T, Kikkawa N, Yamamoto N, Yoshino H . Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma. Br J Cancer. 2013; 109(10):2636-45. PMC: 3833206. DOI: 10.1038/bjc.2013.607. View

Zhu L, Tu H, Liang Y, Tang D . MiR-218 produces anti-tumor effects on cervical cancer cells in vitro. World J Surg Oncol. 2018; 16(1):204. PMC: 6186038. DOI: 10.1186/s12957-018-1506-3. View

Fang F, Huang B, Sun S, Xiao M, Guo J, Yi X . miR-27a inhibits cervical adenocarcinoma progression by downregulating the TGF-βRI signaling pathway. Cell Death Dis. 2018; 9(3):395. PMC: 5847584. DOI: 10.1038/s41419-018-0431-2. View

Wang M, Wang X, Liu W . MicroRNA‑130a‑3p promotes the proliferation and inhibits the apoptosis of cervical cancer cells via negative regulation of RUNX3. Mol Med Rep. 2020; 22(4):2990-3000. DOI: 10.3892/mmr.2020.11368. View

Cui F, Li X, Zhu X, Huang L, Huang Y, Mao C . MiR-125b inhibits tumor growth and promotes apoptosis of cervical cancer cells by targeting phosphoinositide 3-kinase catalytic subunit delta. Cell Physiol Biochem. 2012; 30(5):1310-8. DOI: 10.1159/000343320. View

Chen C, Tang J, Xu S, Zhang W, Jiang H . miR-30a-5p Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Targeting FOXD1. Biomed Res Int. 2020; 2020:2547902. PMC: 7174912. DOI: 10.1155/2020/2547902. View

10.

Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G . Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?. Int J Cancer. 2009; 125(2):362-6. DOI: 10.1002/ijc.24339. View

11.

Koncar R, Feldman R, Bahassi E, Sadraei N . Comparative molecular profiling of HPV-induced squamous cell carcinomas. Cancer Med. 2017; 6(7):1673-1685. PMC: 5504316. DOI: 10.1002/cam4.1108. View

12.

Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S . Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016; 4(9):e609-16. DOI: 10.1016/S2214-109X(16)30143-7. View

13.

Du X, Lin L, Zhang L, Jiang J . microRNA-195 inhibits the proliferation, migration and invasion of cervical cancer cells via the inhibition of CCND2 and MYB expression. Oncol Lett. 2015; 10(4):2639-2643. PMC: 4580043. DOI: 10.3892/ol.2015.3541. View

14.

Iorio M, Ferracin M, Liu C, Veronese A, Spizzo R, Sabbioni S . MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005; 65(16):7065-70. DOI: 10.1158/0008-5472.CAN-05-1783. View

15.

Zang W, Yang X, Wang T, Wang Y, Du Y, Chen X . MiR-451 inhibits proliferation of esophageal carcinoma cell line EC9706 by targeting CDKN2D and MAP3K1. World J Gastroenterol. 2015; 21(19):5867-76. PMC: 4438020. DOI: 10.3748/wjg.v21.i19.5867. View

16.

Haeggblom L, Ahrlund-Richter A, Mirzaie L, Farrajota Neves da Silva P, Ursu R, Ramqvist T . Differences in gene expression between high-grade dysplasia and invasive HPV and HPV tonsillar and base of tongue cancer. Cancer Med. 2019; 8(14):6221-6232. PMC: 6797576. DOI: 10.1002/cam4.2450. View

17.

Hui Y, Li Y, Jing Y, Feng J, Ding Y . miRNA-101 acts as a tumor suppressor in oral squamous cell carcinoma by targeting CX chemokine receptor 7. Am J Transl Res. 2016; 8(11):4902-4911. PMC: 5126332. View

18.

Vojtechova Z, Sabol I, Salakova M, Smahelova J, Zavadil J, Turek L . Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones. BMC Cancer. 2016; 16:382. PMC: 4932682. DOI: 10.1186/s12885-016-2430-y. View

19.

Liu X, Zhou Y, Ning Y, Gu H, Tong Y, Wang N . MiR-195-5p Inhibits Malignant Progression of Cervical Cancer by Targeting YAP1. Onco Targets Ther. 2020; 13:931-944. PMC: 6996614. DOI: 10.2147/OTT.S227826. View

20.

Ramdas L, Giri U, Ashorn C, Coombes K, El-Naggar A, Ang K . miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue. Head Neck. 2009; 31(5):642-54. PMC: 2668741. DOI: 10.1002/hed.21017. View